Endocrinology & metabolism
Hormones & metabolism clinical trials
Diabetes, obesity, thyroid, and other conditions of the body’s hormones and metabolism. We’re tracking 7,607 recruiting studies in this area right now.
By phase
- Not applicable5,335
- Phase 2607
- Phase 1557
- Phase 3417
- Phase 4318
- Phase 1/Phase 2288
- Phase 2/Phase 385
Top conditions
- Obesity619
- Ovarian Cancer336
- Pancreatic Cancer289
- Type 2 Diabetes276
- Diabetes192
- Diabetes Mellitus183
- Diabetes Mellitus, Type 2170
- Hypertension138
- Type 1 Diabetes130
- Metabolic Syndrome126
- Obesity & Overweight123
- Breast Cancer111
- Overweight106
- Cardiovascular Diseases105
- Amyotrophic Lateral Sclerosis102
- Colorectal Cancer92
- Pancreas Cancer90
- Endometrial Cancer87
Leading sponsors
- Mayo Clinic87
- Novo Nordisk A/S64
- University of Colorado, Denver53
- Assistance Publique - Hôpitaux de Paris52
- M.D. Anderson Cancer Center41
- Massachusetts General Hospital41
- Eli Lilly and Company40
- IRCCS Azienda Ospedaliero-Universitaria di Bologna40
- National Taiwan University Hospital40
- Cairo University38
Where studies are running
- California521
- Maryland180
- Alabama176
- Arizona170
- Florida166
- Texas158
- Massachusetts151
- New York142
- Colorado115
- Pennsylvania113
Recruiting studies7,607 total
- NCT06633120Recruiting
Growing eggs in the lab for women with PCOS
This study tests a way to mature eggs outside the body for women with PCOS or high ovarian reserve. It might help avoid side effects from fertility medications.
Lone Tree, ColoradoAges Up to 38 years - NCT06632886Recruiting
AI study to find cancers from your past CT scans
This study uses artificial intelligence to look at CT scans you've already had (without dye) to try and find signs of several types of cancer early. It may help find cancer sooner when it's easier to treat.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07717255Recruiting
Testing dialysis adequacy and patient outcomes
This study measures how well a dialysis method called haemodiafiltration removes waste products from the blood, tracks how patients feel, and monitors sodium balance. It aims to improve treatment for people with kidney failure on dialysis.
Stevenage, HertfordshireAges 18 years+ - NCT07721025RecruitingPhase 2
Gene therapy trial for Friedreich ataxia heart disease
This trial tests a one-time gene therapy called LX2006 for heart problems caused by Friedreich ataxia. The goal is to see if it can improve heart function and structure.
Tampa, FloridaAges 6 years+ - NCT07721597RecruitingEarly Phase 1
Testing ZP6590 in Men of Various Weights
This trial tests an experimental medication called ZP6590 given as injections. It's for men who are at a normal weight, overweight, or have obesity, and studies how safe and well-tolerated the drug is in different doses.
Neuss, North Rhine-WestphaliaAges 18–60 - NCT07722546RecruitingPhase 2
Felzartamab for Graves' disease in adults
This study tests an investigational drug called felzartamab to see if it can help control thyroid function in adults with Graves' disease. It may offer a new option if you are still having symptoms despite anti-thyroid medication.
Glendale, ArizonaAges 18–75 - NCT07720271RecruitingPhase 3
Zenagamtide weight loss study for adults
This study is testing a new tablet called Zenagamtide to help people with extra body weight lose weight. It's for adults who are not diabetic and haven't used similar weight loss drugs before.
Anniston, AlabamaAges 18 years+ - NCT06635993Recruiting
Testing a PET scan for aldosterone and cortisol condition
This trial tests whether a special PET/CT scan (68Ga-Pentixafor) can accurately identify the subtype of primary aldosteronism in people who also have excess cortisol. It may help determine if surgery is the right treatment for you.
Chongqing, Chongqing MunicipalityAges Any age - NCT07715955Recruiting
Can probiotics help control appetite in adults with overweight or obesity?
This study tests whether taking probiotics can help regulate appetite in people who are overweight or have obesity. It aims to understand if these supplements can support weight management by affecting hunger and fullness signals.
Maastricht, LimburgAges 20–70 - NCT07718854RecruitingPhase 2
Study of two drugs for advanced ovarian clear cell cancer
This study tests two investigational drugs, alone or together, for advanced ovarian clear cell cancer that has not responded to usual treatments. The goal is to see if these drugs help shrink or control the cancer.
Boston, MassachusettsAges 18 years+ - NCT07716397Recruiting
MRI study for thyroid eye disease diagnosis and care
This study uses MRI scans of the eye area to better understand and classify thyroid eye disease (TED). It aims to help doctors predict outcomes and personalize treatment. You may be eligible if you have stable TED or are a healthy volunteer.
Shanghai, Huangpu DistrictAges 18–75 - NCT07720388Recruiting
Spanish-language training for the Medtronic 780G insulin pump
This study helps Latino patients with type 1 diabetes learn to use the Medtronic MiniMed 780G insulin pump in Spanish. The goal is to see if this training makes it easier to manage diabetes with the new technology.
Aurora, ColoradoAges 10–20 - NCT07718217Recruiting
Mindfulness education for women with PCOS
This study tests whether a 4-week online mindfulness program can help women with PCOS manage stress and improve well-being. You'll attend group sessions and complete surveys from home.
BursaAges 18–49 - NCT07719894RecruitingPhase 4
Preventing heart problems in type 2 diabetes with cilostazol and aspirin
This trial tests whether taking cilostazol and aspirin together can help prevent heart attacks, strokes, and other cardiovascular events in people with type 2 diabetes who have early signs of artery disease or metabolic syndrome. It aims to see if this combination is more effective than aspirin alone.
Seongnam-si, Gyeonggi-doAges 19 years+ - NCT07720232RecruitingPhase 4
Probiotic plus lipid-lowering for pancreatitis from high triglycerides
This trial tests if adding a probiotic (Bacillus subtilis and Enterococcus faecium) to standard lipid-lowering therapy helps people with mild pancreatitis caused by very high triglycerides. It aims to see if the combination reduces inflammation and speeds recovery.
Xiamen, FujianAges 18–65 - NCT07718113Recruiting
Exercise Snacking and Heart Health
This study tests whether short 'exercise snacks' (brief bursts of activity throughout the day) can improve your heart and metabolic health. It's for people who are currently not very active and want to see if small, frequent exercise breaks can make a difference.
River Falls, WisconsinAges 18–60 - NCT07717658Recruiting
Family weight wellness program for teens and parents
This study tests a weight wellness program that uses food support and group medical visits for teens and their parents. It aims to help families adopt healthier habits together over 12 months.
Boston, MassachusettsAges 12–17 - NCT07717424Recruiting
Quality of life and emotions in gestational diabetes
This study looks at how gestational diabetes affects your quality of life and emotional well-being. By answering a few questions, it aims to better understand and support women like you.
Ludhiana, PunjabAges 20–40 - NCT07716059Recruiting
Does legume flour in bread affect blood sugar?
This study tests how different sizes of legume flour in bread affect your body's blood sugar response. If you are a healthy adult or have type 2 diabetes, you may be able to participate.
Athens, AtticaAges 18–75 - NCT07717554Recruiting
Virtual yoga for diabetic stomach-pain relief
This study tests if virtual yoga classes can help people with diabetes and gastroparesis (slow stomach emptying) feel better. It looks at whether yoga can ease symptoms like nausea, bloating, and stomach pain.
Columbus, OhioAges 18–65 - NCT07717333Recruiting
Sarcopenia signs after weight loss surgery
This study looks at muscle changes after bariatric (weight loss) surgery. It may help you understand how your muscles are affected and what you can do to stay strong.
Istanbul, KÜÇÜKÇEKMECEAges 18–65 - NCT07722910Recruiting
Iris blood flow in diabetic neovascular glaucoma
This study uses a special camera (OCTA) to look at blood flow in the iris of people with or without type 2 diabetes and diabetic neovascular glaucoma. The goal is to understand how blood flow changes in this eye condition.
Jinan, ShandongAges 18 years+ - NCT07720414Recruiting
GLP-1 Meds and Breastfeeding Study
This study tests whether a type of diabetes/weight loss medication (GLP-1 RA, given as a shot) affects milk production in breastfeeding mothers. It may help women who need this medicine while nursing.
Aurora, ColoradoAges Any age - NCT07718997RecruitingPhase 1
Social skills training for people with sex chromosome differences
This trial tests a social management training program for adults with sex chromosome aneuploidies (SCA). The goal is to see if it can help improve social skills and daily life. It is a small feasibility study to prepare for larger future trials.
OsloAges 16–65
Common questions
- How many hormones & metabolism clinical trials are recruiting?
- Clin2 is tracking 7,607 recruiting endocrinology & metabolism studies from the U.S. registry right now, out of 11,814 we cover in this area in total.
- What does “Hormones & metabolism” cover here?
- Diabetes, obesity, thyroid, and other conditions of the body’s hormones and metabolism. We group each study into hormones & metabolism based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a hormones & metabolism trial near me?
- Use the search to filter hormones & metabolism studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.